当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Can innate immune system targets turn up the heat on 'cold' tumours?
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-12-28 , DOI: 10.1038/nrd.2017.264 Asher Mullard
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-12-28 , DOI: 10.1038/nrd.2017.264 Asher Mullard
Can innate immune system targets turn up the heat on 'cold' tumours?
中文翻译:
先天性免疫系统靶点能否提高“冷”肿瘤的热量?
先天性免疫系统靶点能否提高“冷”肿瘤的热量?
更新日期:2017-12-31
Can innate immune system targets turn up the heat on 'cold' tumours?, Published online: 28 December 2018; doi:10.1038/nrd.2017.264
STING, RIG-I and NLRP3 agonists might increase the effectiveness of immuno-oncology checkpoint inhibitors, while antagonists of these targets offer an anti-inflammatory bonus.中文翻译:
先天性免疫系统靶点能否提高“冷”肿瘤的热量?
先天性免疫系统靶点能否提高“冷”肿瘤的热量?
先天性免疫系统靶点能否提高``冷''肿瘤的发热量?在线发表于:2018年12月28日; doi:10.1038 / nrd.2017.264
STING,RIG-1和NLRP3激动剂可能会提高免疫肿瘤检查点抑制剂的效力,而这些靶点的拮抗剂可提供抗炎作用。